Ken Griffin Ark Genomic Revolution ETF (De Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 346,700 shares of ARKG stock, worth $8.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
346,700
Previous 666,200
47.96%
Holding current value
$8.75 Million
Previous $13.8 Million
38.96%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARKG
# of Institutions
279Shares Held
18.9MCall Options Held
3.97MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$86.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$80.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$53.7 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$34.1 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$27.4 Million0.01% of portfolio